Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Upadacitinib effectively treats pyoderma gangrenosum.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Olanzapine reduces stress-related anxiety in rats when given acutely.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.